REZOLUTE, INC. Debt Instrument, Interest Rate, Stated Percentage
REZOLUTE, INC. (RZLT) had Debt Instrument, Interest Rate, Stated Percentage of 20.00% as of 2018-04-11, per its 10-K filed 2018-10-15.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentInterestRateStatedPercentage · last filed 2019-05-10
- 2018-04-11: Debt Instrument, Interest Rate, Stated Percentage 20.00%.
- 2018-04-03: Debt Instrument, Interest Rate, Stated Percentage 20.00%.
- 2015-03-31: Debt Instrument, Interest Rate, Stated Percentage 8.00%.
- 2014-01-31: Debt Instrument, Interest Rate, Stated Percentage 8.00%.
| Period end | Debt Instrument, Interest Rate, Stated Percentage |
|---|---|
| 2018-04-11 | 20.00% 10-K · filed 2018-10-15 |
| 2018-04-03 | 20.00% 10-Q · filed 2019-05-10 |
| 2015-03-31 | 8.00% 10-Q · filed 2015-05-15 |
| 2014-01-31 | 8.00% 10-Q · filed 2014-05-14 |
| 2013-12-31 | 8.00% 10-K · filed 2014-09-30 |
| 2012-12-31 | 8.00% 10-Q · filed 2015-05-15 |
| 2012-07-31 | 8.00% 10-Q · filed 2015-05-15 |
| 2011-12-31 | 8.00% 10-Q · filed 2014-02-13 |
| 2011-06-30 | 8.00% 10-Q · filed 2015-05-15 |
| 2010-12-31 | 8.00% 10-Q · filed 2014-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |